Categories: News

National Research Corporation to Broadcast its 2021 Fourth Quarter Conference Call Live on the Internet

Lincoln, Nebraska, Jan. 27, 2022 (GLOBE NEWSWIRE) — National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2021 fourth quarter earnings conference call on Wednesday, February 9, 2022. The Company’s results for the 2021 fourth quarter will be released after the close of the market on Tuesday, February 8, 2022.

The live broadcast of National Research Corporation’s conference call will begin at 11:00 a.m. Eastern Time on February 9, 2022. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. 

A live audio webcast can be accessed at https://events.q4inc.com/attendee/203117621. The webcast will also be available for replay.

For more than 40 years, National Research Corporation has been a leading provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers and other healthcare organizations. Our purpose is to enable human understanding by helping our clients to understand the voice of the customer with greater clarity, immediacy and depth.

-END-

 

CONTACT: Kevin Karas
Chief Financial Officer
402-475-2525

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

4 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

7 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

7 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

7 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

7 hours ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

7 hours ago